Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings

Adjuvants are critical components of vaccines that enhance the host immune response to the vaccine antigen, however, only a small number of adjuvants are used in vaccines approved for human use. This is in part due to the slow process of novel adjuvants advancing from preclinical models to human stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human vaccines & immunotherapeutics 2023-08, Vol.19 (2), p.2223503-2223503
Hauptverfasser: Vázquez-Maldonado, Nancy, Kelly, Halonna R., Leitner, Wolfgang W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2223503
container_issue 2
container_start_page 2223503
container_title Human vaccines & immunotherapeutics
container_volume 19
creator Vázquez-Maldonado, Nancy
Kelly, Halonna R.
Leitner, Wolfgang W.
description Adjuvants are critical components of vaccines that enhance the host immune response to the vaccine antigen, however, only a small number of adjuvants are used in vaccines approved for human use. This is in part due to the slow process of novel adjuvants advancing from preclinical models to human studies, and modest mechanistic insights obtained using standard immunological methods to justify selection of a particular adjuvant for clinical evaluation. Here, we discuss several aspects of current adjuvant research and strategies to better assess the complex pathways triggered by adjuvant candidates that can increase adjuvanticity and vaccine efficacy while minimizing reactogenicity. We propose a more systematic use of broad immunoprofiling, coupled with data integration using computational and mathematical modeling. This comprehensive evaluation of the host immune response will facilitate the selection of the most appropriate adjuvant for a vaccine, ultimately leading to the expeditious evaluation of novel adjuvants for vaccines against emerging infectious diseases, which will prove especially valuable during a pandemic where speed is of the essence when developing vaccines.
doi_str_mv 10.1080/21645515.2023.2223503
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_21645515_2023_2223503</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_11eeff7beb274f0c9c588fe83c41810f</doaj_id><sourcerecordid>2828361603</sourcerecordid><originalsourceid>FETCH-LOGICAL-c535t-4115e25f0765b82a8975061dac44f3831d7d85239e4644f046957eb7e2cd49153</originalsourceid><addsrcrecordid>eNp9kkuP0zAUhSMEYkbD_ARQlmxa_I7LBkYVj5FGYgMSO-vGue64SuxgJ0X997j0IWaDN7auz_mur3yq6jUlS0o0eceoElJSuWSE8SVjjEvCn1XXh_pCSvHz-eVM5VV1m_OWlNUQJpR6WV3xhgsqmb6u5nUcxoSPGLLfYe2HYQ5xTNH53odNDaGr8z5POMDkbQ3ddt5BmGpbXJB8jiHXLqbadxgm7_YHT579BG2P9Q6s9QHf13dn2wg-FUl-Vb1w0Ge8Pe031Y_Pn76vvy4evn25X989LKzkcloISiUy6UijZKsZ6FUjiaIdWCEc15x2Tacl4ysUqlSIUCvZYNsgs51YUclvqvsjt4uwNWPyA6S9ieDN30JMGwOpDNajoRTRuabFljUFZVdWau1QcyuopsQV1ocja5zbATtbBk7QP4E-vQn-0WzizlDCtFJaFcLbEyHFXzPmyQw-W-x7CBjnbJhmmiuqCC9SeZTaFHNO6C59KDGHCJhzBMwhAuYUgeJ78-8jL67zhxfBx6PAh_JvA_yOqe_MBPs-JpcgWJ8N_3-PPxqawvw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2828361603</pqid></control><display><type>article</type><title>Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Access via Taylor &amp; Francis (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Vázquez-Maldonado, Nancy ; Kelly, Halonna R. ; Leitner, Wolfgang W.</creator><creatorcontrib>Vázquez-Maldonado, Nancy ; Kelly, Halonna R. ; Leitner, Wolfgang W.</creatorcontrib><description>Adjuvants are critical components of vaccines that enhance the host immune response to the vaccine antigen, however, only a small number of adjuvants are used in vaccines approved for human use. This is in part due to the slow process of novel adjuvants advancing from preclinical models to human studies, and modest mechanistic insights obtained using standard immunological methods to justify selection of a particular adjuvant for clinical evaluation. Here, we discuss several aspects of current adjuvant research and strategies to better assess the complex pathways triggered by adjuvant candidates that can increase adjuvanticity and vaccine efficacy while minimizing reactogenicity. We propose a more systematic use of broad immunoprofiling, coupled with data integration using computational and mathematical modeling. This comprehensive evaluation of the host immune response will facilitate the selection of the most appropriate adjuvant for a vaccine, ultimately leading to the expeditious evaluation of novel adjuvants for vaccines against emerging infectious diseases, which will prove especially valuable during a pandemic where speed is of the essence when developing vaccines.</description><identifier>ISSN: 2164-5515</identifier><identifier>EISSN: 2164-554X</identifier><identifier>DOI: 10.1080/21645515.2023.2223503</identifier><identifier>PMID: 37341528</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Acceptance ; Adjuvant ; Adjuvants, Immunologic ; Humans ; immunoprofiling ; immunostimulators ; reactogenicity ; Vaccines</subject><ispartof>Human vaccines &amp; immunotherapeutics, 2023-08, Vol.19 (2), p.2223503-2223503</ispartof><rights>This work was authored as part of the Contributor's official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 U.S.C. 105, no copyright protection is available for such works under U.S. Law.</rights><rights>This work was authored as part of the Contributor’s official duties as an Employee of the United States Government and is therefore a work of the United States Government. In accordance with 17 USC 105, no copyright protection is available for such works under US Law. None</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c535t-4115e25f0765b82a8975061dac44f3831d7d85239e4644f046957eb7e2cd49153</citedby><cites>FETCH-LOGICAL-c535t-4115e25f0765b82a8975061dac44f3831d7d85239e4644f046957eb7e2cd49153</cites><orcidid>0000-0003-3125-5922 ; 0009-0006-7946-5792</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286686/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286686/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,27502,27924,27925,53791,53793,59143,59144</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37341528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vázquez-Maldonado, Nancy</creatorcontrib><creatorcontrib>Kelly, Halonna R.</creatorcontrib><creatorcontrib>Leitner, Wolfgang W.</creatorcontrib><title>Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings</title><title>Human vaccines &amp; immunotherapeutics</title><addtitle>Hum Vaccin Immunother</addtitle><description>Adjuvants are critical components of vaccines that enhance the host immune response to the vaccine antigen, however, only a small number of adjuvants are used in vaccines approved for human use. This is in part due to the slow process of novel adjuvants advancing from preclinical models to human studies, and modest mechanistic insights obtained using standard immunological methods to justify selection of a particular adjuvant for clinical evaluation. Here, we discuss several aspects of current adjuvant research and strategies to better assess the complex pathways triggered by adjuvant candidates that can increase adjuvanticity and vaccine efficacy while minimizing reactogenicity. We propose a more systematic use of broad immunoprofiling, coupled with data integration using computational and mathematical modeling. This comprehensive evaluation of the host immune response will facilitate the selection of the most appropriate adjuvant for a vaccine, ultimately leading to the expeditious evaluation of novel adjuvants for vaccines against emerging infectious diseases, which will prove especially valuable during a pandemic where speed is of the essence when developing vaccines.</description><subject>Acceptance</subject><subject>Adjuvant</subject><subject>Adjuvants, Immunologic</subject><subject>Humans</subject><subject>immunoprofiling</subject><subject>immunostimulators</subject><subject>reactogenicity</subject><subject>Vaccines</subject><issn>2164-5515</issn><issn>2164-554X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><sourceid>DOA</sourceid><recordid>eNp9kkuP0zAUhSMEYkbD_ARQlmxa_I7LBkYVj5FGYgMSO-vGue64SuxgJ0X997j0IWaDN7auz_mur3yq6jUlS0o0eceoElJSuWSE8SVjjEvCn1XXh_pCSvHz-eVM5VV1m_OWlNUQJpR6WV3xhgsqmb6u5nUcxoSPGLLfYe2HYQ5xTNH53odNDaGr8z5POMDkbQ3ddt5BmGpbXJB8jiHXLqbadxgm7_YHT579BG2P9Q6s9QHf13dn2wg-FUl-Vb1w0Ge8Pe031Y_Pn76vvy4evn25X989LKzkcloISiUy6UijZKsZ6FUjiaIdWCEc15x2Tacl4ysUqlSIUCvZYNsgs51YUclvqvsjt4uwNWPyA6S9ieDN30JMGwOpDNajoRTRuabFljUFZVdWau1QcyuopsQV1ocja5zbATtbBk7QP4E-vQn-0WzizlDCtFJaFcLbEyHFXzPmyQw-W-x7CBjnbJhmmiuqCC9SeZTaFHNO6C59KDGHCJhzBMwhAuYUgeJ78-8jL67zhxfBx6PAh_JvA_yOqe_MBPs-JpcgWJ8N_3-PPxqawvw</recordid><startdate>20230801</startdate><enddate>20230801</enddate><creator>Vázquez-Maldonado, Nancy</creator><creator>Kelly, Halonna R.</creator><creator>Leitner, Wolfgang W.</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Group</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3125-5922</orcidid><orcidid>https://orcid.org/0009-0006-7946-5792</orcidid></search><sort><creationdate>20230801</creationdate><title>Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings</title><author>Vázquez-Maldonado, Nancy ; Kelly, Halonna R. ; Leitner, Wolfgang W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c535t-4115e25f0765b82a8975061dac44f3831d7d85239e4644f046957eb7e2cd49153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Acceptance</topic><topic>Adjuvant</topic><topic>Adjuvants, Immunologic</topic><topic>Humans</topic><topic>immunoprofiling</topic><topic>immunostimulators</topic><topic>reactogenicity</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vázquez-Maldonado, Nancy</creatorcontrib><creatorcontrib>Kelly, Halonna R.</creatorcontrib><creatorcontrib>Leitner, Wolfgang W.</creatorcontrib><collection>Access via Taylor &amp; Francis (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Human vaccines &amp; immunotherapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vázquez-Maldonado, Nancy</au><au>Kelly, Halonna R.</au><au>Leitner, Wolfgang W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings</atitle><jtitle>Human vaccines &amp; immunotherapeutics</jtitle><addtitle>Hum Vaccin Immunother</addtitle><date>2023-08-01</date><risdate>2023</risdate><volume>19</volume><issue>2</issue><spage>2223503</spage><epage>2223503</epage><pages>2223503-2223503</pages><issn>2164-5515</issn><eissn>2164-554X</eissn><abstract>Adjuvants are critical components of vaccines that enhance the host immune response to the vaccine antigen, however, only a small number of adjuvants are used in vaccines approved for human use. This is in part due to the slow process of novel adjuvants advancing from preclinical models to human studies, and modest mechanistic insights obtained using standard immunological methods to justify selection of a particular adjuvant for clinical evaluation. Here, we discuss several aspects of current adjuvant research and strategies to better assess the complex pathways triggered by adjuvant candidates that can increase adjuvanticity and vaccine efficacy while minimizing reactogenicity. We propose a more systematic use of broad immunoprofiling, coupled with data integration using computational and mathematical modeling. This comprehensive evaluation of the host immune response will facilitate the selection of the most appropriate adjuvant for a vaccine, ultimately leading to the expeditious evaluation of novel adjuvants for vaccines against emerging infectious diseases, which will prove especially valuable during a pandemic where speed is of the essence when developing vaccines.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>37341528</pmid><doi>10.1080/21645515.2023.2223503</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3125-5922</orcidid><orcidid>https://orcid.org/0009-0006-7946-5792</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2164-5515
ispartof Human vaccines & immunotherapeutics, 2023-08, Vol.19 (2), p.2223503-2223503
issn 2164-5515
2164-554X
language eng
recordid cdi_crossref_primary_10_1080_21645515_2023_2223503
source MEDLINE; DOAJ Directory of Open Access Journals; Access via Taylor & Francis (Open Access Collection); PubMed Central; Alma/SFX Local Collection
subjects Acceptance
Adjuvant
Adjuvants, Immunologic
Humans
immunoprofiling
immunostimulators
reactogenicity
Vaccines
title Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A48%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comprehensive%20immunoprofiling%20and%20systematic%20adjuvant%20comparisons%20for%20identifying%20suitable%20vaccine:%20Adjuvant%20pairings&rft.jtitle=Human%20vaccines%20&%20immunotherapeutics&rft.au=V%C3%A1zquez-Maldonado,%20Nancy&rft.date=2023-08-01&rft.volume=19&rft.issue=2&rft.spage=2223503&rft.epage=2223503&rft.pages=2223503-2223503&rft.issn=2164-5515&rft.eissn=2164-554X&rft_id=info:doi/10.1080/21645515.2023.2223503&rft_dat=%3Cproquest_cross%3E2828361603%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2828361603&rft_id=info:pmid/37341528&rft_doaj_id=oai_doaj_org_article_11eeff7beb274f0c9c588fe83c41810f&rfr_iscdi=true